New York-based Jones just raised $10 million to expand its nicotine lozenge company in the stodgy, $3 billion smoking cessation market.
Philip Morris International shows robust growth in smoke-free products. Find out why PM stock remains a solid buy with ...
Q4 2024 Management View CEO Ameet Mallik highlighted that 2024 was focused on execution, achieving key milestones, advancing ZYNLONTA, and strengthening the balance sheet. The company completed ...
Philip Morris is soaring on the Zyn nicotine pouch craze and is now in a valid base, trading just below a buy point.